Commerzbank Aktiengesellschaft’s Myriad Genetics MYGN Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-20,000	Closed	-$573K	–	772
2019 Q3	$573K	Hold	20,000	–	–	﹤0.01%	625
2019 Q2	$556K	Hold	20,000	–	–	﹤0.01%	724
2019 Q1	$664K	Hold	20,000	–	–	0.01%	574
2018 Q4	$581K	Hold	20,000	–	–	0.01%	639
2018 Q3	$920K	Hold	20,000	–	–	0.01%	575
2018 Q2	$747K	Hold	20,000	–	–	0.01%	586
2018 Q1	$591K	Hold	20,000	–	–	0.01%	645
2017 Q4	$687K	Hold	20,000	–	–	0.01%	599
2017 Q3	$724K	Hold	20,000	–	–	0.01%	523
2017 Q2	$517K	Sell	20,000 -1,733	-8%	-$36.8K	0.01%	516
2017 Q1	$417K	Buy	21,733 +357	+2%	+$6.33K	0.01%	696
2016 Q4	$356K	Buy	21,376 +301	+1%	+$5.45K	0.01%	718
2016 Q3	$434K	Sell	21,075 -5,662	-21%	-$144K	0.01%	607
2016 Q2	$818	Sell	26,737 -146	-0.5%	-$5.07K	0.01%	524
2016 Q1	$1.01M	Buy	26,883 +4,879	+22%	+$184K	0.01%	501
2015 Q4	$950K	Buy	22,004 +9,804	+80%	+$414K	0.01%	672
2015 Q3	$457K	Sell	12,200 -12,827	-51%	-$455K	﹤0.01%	804
2015 Q2	$851K	Sell	25,027 -407	-2%	-$13.8K	﹤0.01%	856
2015 Q1	$900K	Buy	25,434 +17,024	+202%	+$609K	0.01%	816
2014 Q4	$286K	Sell	8,410 -10,435	-55%	-$370K	﹤0.01%	1082
2014 Q3	$727K	Buy	+18,845	New	+$703K	﹤0.01%	894
2013 Q3	–	Sell	-7,689	Closed	-$207K	–	1373
2013 Q2	$207K	Buy	+7,689	New	+$223K	﹤0.01%	1366

Other funds holding MYGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Commerzbank Aktiengesellschaft's MYGN Position: Q4 2019 in Review

Commerzbank Aktiengesellschaft sold out of Myriad Genetics (MYGN) in Q4 2019, closing a stake of 20,000 shares — an estimated $573K sold.

Commerzbank Aktiengesellschaft first reported a position in MYGN in Q2 2013 and held it in 22 quarters. The position peaked at $1.01M in Q1 2016. 227 funds tracked by Wall St. Rank hold MYGN as of Q4 2019.

Commerzbank Aktiengesellschaft reported no remaining Myriad Genetics position as of Q4 2019 after selling out during the quarter.
Commerzbank Aktiengesellschaft sold 20,000 Myriad Genetics shares in Q4 2019, an estimated $573K.
Commerzbank Aktiengesellschaft first reported a position in Myriad Genetics in Q2 2013 and held it in 22 quarters.
Commerzbank Aktiengesellschaft's Myriad Genetics position peaked at $1.01M in Q1 2016.
227 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2019.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q4 2019, filed 17 Jan 2020.